| Product NDC: | 51079-446 |
| Proprietary Name: | Desmopressin Acetate |
| Non Proprietary Name: | Desmopressin Acetate |
| Active Ingredient(s): | .2 mg/1 & nbsp; Desmopressin Acetate |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 51079-446 |
| Labeler Name: | UDL Laboratories, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA077122 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20110825 |
| Package NDC: | 51079-446-03 |
| Package Description: | 30 BLISTER PACK in 1 BOX, UNIT-DOSE (51079-446-03) > 1 TABLET in 1 BLISTER PACK (51079-446-01) |
| NDC Code | 51079-446-03 |
| Proprietary Name | Desmopressin Acetate |
| Package Description | 30 BLISTER PACK in 1 BOX, UNIT-DOSE (51079-446-03) > 1 TABLET in 1 BLISTER PACK (51079-446-01) |
| Product NDC | 51079-446 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Desmopressin Acetate |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 20110825 |
| Marketing Category Name | ANDA |
| Labeler Name | UDL Laboratories, Inc. |
| Substance Name | DESMOPRESSIN ACETATE |
| Strength Number | .2 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Factor VIII Activator [EPC],Increased Coagulation Factor VIII Activity [PE],Increased Coagulation Factor VIII Concentration [PE],Vasopressin Analog [EPC],Vasopressins [Chemical/Ingredient] |